Biotech Stock Roundup: VYGR Gains From NVS Deal, AGIO Up on Study Data & More
https://www.zacks.com/stock/news/2205605/biotech-stock-roundup-vygr-gains-from-nvs-deal-agio-up-on-study-data-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2205605
Jan 04, 2024 - Collaboration news from Voyager (VYGR) and study updates from Agios (AGIO) are the key highlights this week.
0
Ligand (LGND) Up 9% on FDA Nod for Molluscum Infection Gel
https://www.zacks.com/stock/news/2207168/ligand-lgnd-up-9-on-fda-nod-for-molluscum-infection-gel?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2207168
Jan 08, 2024 - Following the FDA approval, Ligand's (LGND) Zelsuvmi is the first at-home treatment option available for molluscum contagiosum.
0
Pebblebrook (PEB) Extends Term Loan Maturity, Ups Flexibility
https://www.zacks.com/stock/news/2206897/pebblebrook-peb-extends-term-loan-maturity-ups-flexibility?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2206897
Jan 08, 2024 - Pebblebrook (PEB) boosts financial flexibility and lowers total debt outstanding by extending its October 2024 term loan to January 2028 and repaying part of the maturing private notes.
0
United Parcel Service (UPS) Advances While Market Declines: Some Information for Investors
https://www.zacks.com/stock/news/2207830/united-parcel-service-ups-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2207830
Jan 09, 2024 - In the closing of the recent trading day, United Parcel Service (UPS) stood at $159.94, denoting a +0.01% change from the preceding trading day.
0
Abercrombie & Fitch (ANF) Is Up 2.63% in One Week: What You Should Know
https://www.zacks.com/stock/news/2207702/abercrombie-fitch-anf-is-up-2-63-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2207702
Jan 09, 2024 - Does Abercrombie & Fitch (ANF) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
5 Value Stocks With Strong Earnings Yield to Rev Up Returns
https://www.zacks.com/stock/news/2208089/5-value-stocks-with-strong-earnings-yield-to-rev-up-returns?cid=CS-ZC-FT-analyst_blog|rw-2208089
Jan 10, 2024 - Consider investing in high-yield value stocks like GCT, SKYW, METC, EMN and CPRX to unlock your portfolio's potential.
0
Accenture (ACN) to Snap Up Work & Co, Boost Digital Capabilities
https://www.zacks.com/stock/news/2208359/accenture-acn-to-snap-up-work-co-boost-digital-capabilities?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2208359
Jan 10, 2024 - Accenture (ACN) maintains a disciplined acquisition strategy focused on channelizing its business in high-growth areas.
0
C4 (CCCC) Up 6% on Restructuring Plan to Curb Cash Burn
https://www.zacks.com/stock/news/2209026/c4-cccc-up-6-on-restructuring-plan-to-curb-cash-burn?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2209026
Jan 11, 2024 - The new restructuring plan will allow C4 Therapeutics (CCCC) to extend its cash runway into 2027. The company plans to reduce its workforce by nearly 30%.
0
Zymeworks Inc. (ZYME) Is Up 1.64% in One Week: What You Should Know
https://www.zacks.com/stock/news/2209072/zymeworks-inc-zyme-is-up-1-64-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2209072
Jan 11, 2024 - Does Zymeworks Inc. (ZYME) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Regeneron (REGN) Is Up 3.97% in One Week: What You Should Know
https://www.zacks.com/stock/news/2209670/regeneron-regn-is-up-3-97-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2209670
Jan 12, 2024 - Does Regeneron (REGN) have what it takes to be a top stock pick for momentum investors? Let's find out.
0